Filing Details
- Accession Number:
- 0001209191-11-044156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-15 12:47:39
- Reporting Period:
- 2011-08-11
- Filing Date:
- 2011-08-15
- Accepted Time:
- 2011-08-15 12:47:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178879 | Amicus Therapeutics Inc | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1400973 | F John Crowley | C/O Amicus Therapeutics, Inc. 6 Cedar Brook Drive Cranbury NJ 08512 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-11 | 10,000 | $4.20 | 109,867 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $4.06 to $4.34. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.